Description
Xgeva (denosumab) is used to prevent skeletal-related events in patients with bone metastases from solid tumors.
Xgeva (denosumab)
$765.45
RANKL inhibitor for bone complications in cancer
Breaking News
$765.45
RANKL inhibitor for bone complications in cancer
Xgeva (denosumab) is used to prevent skeletal-related events in patients with bone metastases from solid tumors.
Reviews
There are no reviews yet.